开拓全球TFT半导体
产业化新应用

新型光电领域

领挚科技基于核心的TFT半导体技术,首创推出了一系列标准化便携式产品,包括传感系列、显示系列、量测系列等,为光电探测、新型发光显示、传感器电信号量测等多种研究场景,提供从TFT芯片、系统、工艺到技术支持的一站式服务。同时,持续向海内外客户提供TFT芯片设计和定制化服务。

生命科学领域

领挚科技以TFT半导体技术赋能生命科学,打造了世界首台基于TFT半导体技术的DNA合成仪,以及技术水平领先的寡核苷酸微阵列及寡核苷酸池,实现了从终端设备、量产耗材到合成产物的业务生态,为从事合成生物学、高通量组学技术、创新药研发、医学检测、分子育种等领域的公司和科研机构,提供高效率合成解决方案。并有望基于自研的TFT半导体生物芯片平台,构建全流程集成化的下一代生命科学工具。

业务亮点

业务亮点

关于我们

300

+

全球客户

20

+

覆盖国家与地区

200

+

助力高影响力期刊论文

40%

+

海外业务占比

领挚科技全球布局​

英国子公司

The Bradfield Centre, 184 Cambridge Science Park, Milton Road, Cambridge CB4 OGA, UK

中国总部

浙江省杭州市余杭区五常街道华立181社区南区B1栋

领挚科技全球布局​

英国子公司

The Bradfield Centre, 184 Cambridge Science Park, Milton Road, Cambridge CB4 OGA, UK

中国总部

浙江省杭州市余杭区五常街道华立181社区南区B1栋

参展预告

国际基因工程机器大赛 (iGEM) 2025

领挚科技携世界首台基于TFT半导体
技术的DNA微阵列合成仪亮相

2025年10月28日-10月31日

法国巴黎会议中心

Dr. Kang Kang

Partner & CBio

Dr. Kang received his Ph.D. in Bioinformatics and Systems Biology from the University of Hong Kong in 2018, then became a scientific co-worker of the Leibniz Association (Leibniz-HKI) and a visiting scientist at the Novo Nordisk Foundation Center for Biosustainability (DTU Biosustain) at the Technical University of Denmark. He was a scientist at BGI-Shenzhen and co-founded the synthetic biology research group. He was a senior bioinformatics engineer and brand advisor at WeGene. In 2021, Kang joined Biosysen Limited as a co-founder and served as Chief Informatics Scientist. He is also an advisor and author of the biotech media "Regenesis". He has been dedicated to the R&D and industrialization of OMICs technologies, high-throughput technologies, and synthetic biology for over 10 years. He joined LinkZill in March 2023, responsible for semiconductor life science tools and product planning.